Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
"Hi ...... – you can contact our transfer agent to discuss obtaining a physical certificate. Contact info is provided below."
Computershare
P 403-267-6558
Bart WingerakBart.Wingerak@computershare.com